iCAD is a leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of common cancers. iCAD offers a comprehensive range of high-performance, upgradeable CAD solutions for mammography and advanced image analysis and workflow solutions for Magnetic Resonance Imaging, for breast and prostate cancers and Computed Tomography for colorectal cancer. iCAD’s Xoft System, offers radiation treatment for early-stage breast cancer that can be administered in the form of intraoperative radiation therapy or accelerated partial breast irradiation. The Xoft System is also cleared for the treatment of non-melanoma skin cancer and endometrial cancer.
Company Growth (employees)
Type
Public
HQ
Nashua, US
Size (employees)
108 (est)
icad is headquartered in Nashua, US

icad Office Locations

icad has offices in Nashua and San Jose
Nashua, US (HQ)
98 Spit Brook Rd
San Jose, US
101 Nicholson Ln

icad Data and Metrics

icad Financial Metrics

icad's revenue was reported to be $26.3 m in FY, 2016 which is a 37% decrease from the previous period.
$, USD

Revenue (FY, 2016)

26.3 m

Revenue growth (FY, 2015 - FY, 2016), %

(37%)

Gross profit (FY, 2016)

18.5 m

Gross profit margin (FY, 2016), %

70%

Net income (FY, 2016)

(10.1 m)

EBIT (FY, 2016)

(10 m)

Market capitalization (23-Jun-2017)

69.4 m

Closing share price (23-Jun-2017)

4.1

Cash (31-Dec-2016)

8.6 m
icad's current market capitalization is $69.4 m.
$, USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

5.6 m43.9 m41.6 m26.3 m

Revenue growth, %

684%(5%)(37%)

Cost of goods sold

10 m12.7 m12.2 m7.8 m

Gross profit

(4.4 m)31.2 m29.4 m18.5 m

Gross profit Margin, %

(78%)71%71%70%

Operating expense total

24.9 m30.4 m59.4 m28.5 m

EBIT

(1.8 m)815 k(30.1 m)(10 m)

EBIT margin, %

(32%)2%(72%)(38%)

Interest expense

3.3 m2.6 m650 k63 k

Interest income

19 k37 k21 k10 k

Income tax expense

126 k153 k16 k76 k

Net Income

(7.6 m)(1 m)(32.4 m)(10.1 m)
$, USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

11.9 m32.2 m15.3 m8.6 m

Inventories

649 k540 k684 k1.1 m

Current Assets

22 m44.6 m27.8 m19.9 m

Goodwill

21.1 m27.3 m14.2 m14.1 m

Total Assets

58.9 m93.8 m48.6 m38.7 m

Accounts Payable

2 m2.2 m1.6 m1.6 m

Current Liabilities

22.5 m22 m14.3 m12.9 m

Additional Paid-in Capital

166.7 m209.1 m211.5 m213.9 m

Retained Earnings

(144.1 m)(145.1 m)(177.5 m)(187.6 m)

Total Equity

21.4 m62.8 m32.7 m25 m

Financial Leverage

2.8 x1.5 x1.5 x1.5 x
$, USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(7.6 m)(1 m)(32.4 m)(10.1 m)

Depreciation and Amortization

706 k1.3 m1.6 m1.3 m

Accounts Receivable

(2.7 m)(840 k)1.8 m2.2 m

Inventories

228 k(323 k)(2 m)596 k

Accounts Payable

60 k150 k(557 k)(16 k)

Cash From Operating Activities

(1.4 m)3.2 m(1.9 m)(5.5 m)

Purchases of PP&E

(539 k)(1.2 m)(932 k)(337 k)

Cash From Investing Activities

(707 k)(4.7 m)(2.7 m)(355 k)

Cash From Financing Activities

72 k21.9 m(12.4 m)(862 k)

Interest Paid

2.2 m1.6 m558 k70 k

Income Taxes Paid

78 k157 k128 k67 k
Y, 2016

Financial Leverage

1.5 x

icad Market Value History

icad Online and Social Media Presence

icad Company Life and Culture

You may also be interested in